Literature DB >> 529681

Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.

D H Clyne, A J Pesce, R E Thompson.   

Abstract

Bence Jones proteins (BJP) were isolated from the urine of 12 patients with multiple myeloma and various degrees of renal dysfunction. Proteins were characterized as to type (six type lambda and five type kappa), isoelectric point (pI), and secondary structure by circular dichroism (CD). Clinical renal function was more impaired with type-lambda proteins and with proteins of pI greater than 5.7. CD studies distinguished kappa from lambda proteins in most cases but did not correlate with nephrotoxicity. Protein dimer preparations were tested for nephrotoxicity in aciduric, hydropenic, female, Sprague Dawley rats by following renal function and morphology over 6 hours after injection i.p. of 300 mg of protein. Twelve rats of urine pH less than 5.5 injected with four BJP of pI less than 5.7 showed a mean rise in SUN of 5.3 mg/dl and in creatinine of 0.06 mg/dl, compared with a mean rise of 28.0 mg/dl (SUN) and 0.75 mg/dl (creatinine) in 21 rats injected with seven BJP of pI greater than 5.7 (P less than 0.01). Seven sodium-bicarbonate-fed rats of urine pH greater than 8 injected with a BJP of pI 6.2 showed mean rise in SUN of 1.8 mg/dl and in creatinine of 0.01 mg/dl, compared with 19.3 mg/dl (SUN) and 0.55 mg/dl (creatinine) in 7 aciduric rats injected with the same BJP (P = 0.009). Morphologic and immunohistologic studies showed distal cast formation in 9 rats with acute deterioration in renal function. It is concluded that BJP of pI greater than urine pH are acutely nephrotoxic in the rat by a mechanism that may involve a charge interaction in the distal nephron.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 529681     DOI: 10.1038/ki.1979.137

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  16 in total

1.  Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.

Authors:  E A Johns; R Turner; E H Cooper; I C Maclennan
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

2.  Calcium oxalate monohydrate aggregation induced by aggregation of desialylated Tamm-Horsfall protein.

Authors:  Pragasam Viswanathan; Jeffrey D Rimer; Ann M Kolbach; Michael D Ward; Jack G Kleinman; Jeffrey A Wesson
Journal:  Urol Res       Date:  2011-01-13

3.  The kidney in myeloma.

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-04

4.  Renal impairment in myeloma: negative association with isoelectric point of excreted Bence-Jones protein.

Authors:  A G Norden; F V Flynn; L M Fulcher; J D Richards
Journal:  J Clin Pathol       Date:  1989-01       Impact factor: 3.411

5.  Differential nephrotoxicity of low molecular weight proteins including Bence Jones proteins in the perfused rat nephron in vivo.

Authors:  P W Sanders; G A Herrera; A Chen; B B Booker; J H Galla
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 6.  Renal lesions in dysproteinemias.

Authors:  P Verroust; L Morel-Maroger; J L Preud'Homme
Journal:  Springer Semin Immunopathol       Date:  1982

7.  Electrophoretic study of the physico-chemical characteristics of Bence-Jones proteinuria and its association with kidney damage.

Authors:  M C Diemert; L Musset; O Gaillard; S Escolano; A Baumelou; F Rousselet; J Galli
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

8.  Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.

Authors:  Kevin W Finkel; Eric P Cohen; Anushree Shirali; Ala Abudayyeh
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

9.  Myeloma-like cast nephropathy caused by human recombinant soluble CD4 (sCD4) in monkeys.

Authors:  P J Bugelski; H A Solleveld; K L Fong; A M Klinkner; T K Hart; D G Morgan
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

10.  Renal replacement therapy in multiple myeloma and systemic amyloidosis.

Authors:  J H Brown; A P Maxwell; I Bruce; B G Murphy; C C Doherty
Journal:  Ir J Med Sci       Date:  1993-06       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.